Showing results (1-10 of 66) with videos related to
Sort By:
Pageof 7
Comparative Medicine|July 1, 2008
A structured light-based system for scanning subcutaneous tumors in laboratory animalsIbrahim Cem Girit, Maria Jure-Kunkel, Kim W McIntyreBioorganic & Medicinal Chemistry Letters|November 14, 2006
Core exploration in optimization of chemokine receptor CCR4 antagonistsAshok V Purandare, Honghe Wan, John E Somerville, et al.Transplantation|April 17, 2004
A highly selective inhibitor of IkappaB kinase, BMS-345541, augments graft survival mediated by suboptimal immunosuppression in a murine model of cardiac graft rejectionRobert M Townsend, Jennifer Postelnek, Vojkan Susulic, et al.Bioorganic & Medicinal Chemistry Letters|October 21, 2005
Optimization of CCR4 antagonists: side-chain explorationAshok V Purandare, Honghe Wan, Aiming Gao, et al.Journal of Immunology (Baltimore, Md. : 1950)|December 10, 2003
Phosphodiesterase 7A-deficient mice have functional T cellsGuchen Yang, Kim W McIntyre, Robert M Townsend, et al.Arthritis and Rheumatism|September 18, 2003
A highly selective inhibitor of I kappa B kinase, BMS-345541, blocks both joint inflammation and destruction in collagen-induced arthritis in miceKim W McIntyre, David J Shuster, Kathleen M Gillooly, et al.The Journal of Biological Chemistry|October 31, 2002
BMS-345541 is a highly selective inhibitor of I kappa B kinase that binds at an allosteric site of the enzyme and blocks NF-kappa B-dependent transcription in miceJames R Burke, Mark A Pattoli, Kurt R Gregor, et al.Journal of Immunology (Baltimore, Md. : 1950)|March 2, 2010
An LFA-1 (alphaLbeta2) small-molecule antagonist reduces inflammation and joint destruction in murine models of arthritisSuzanne J Suchard, Dawn K Stetsko, Patricia M Davis, et al.Bioorganic & Medicinal Chemistry Letters|January 2, 2007
Synthesis and biological evaluation of 4-amino derivatives of benzimidazoquinoxaline, benzimidazoquinoline, and benzopyrazoloquinazoline as potent IKK inhibitorsFrancis Beaulieu, Carl Ouellet, Edward H Ruediger, et al.Bioorganic & Medicinal Chemistry Letters|August 6, 2002
C-3 Amido-indole cannabinoid receptor modulatorsJohn Hynes, Katerina Leftheris, Hong Wu, et al.Pageof 7